Podcasts about MD

Suit up for summer with the legendary Ford Bronco® SUV, featuring removable doors and roof panels. For current offers, visit http://Ford.com/Local This episode is brought to you by our NY Schlitty shirt! https://shop.jomboymedia.com/discount/802SCHLITTY?redirect=/collections/cam&utm_source=youtube&utm_medium=video&utm_campaign=802SCHLITTY Find out how baseball hits different with T-Mobile at https://www.T-Mobile.com/MLB Try Gusto and get three months free when you run your first payroll: gusto.com/YANKS #ad Download the Fanatics Sportsbook app , use code JOMBOY https://fanatics.onelink.me/5kut/JOMBOY New customers who sign up and Bet $5, Get $100 in FanCash*. Use FanCash on bonus bets, profit boosts, team gear and more on Fanatics.com. *New customers in AZ, CO, CT, DC, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NY, OH, PA, TN, VA, VT, WV, or WY. Must toggle on this promotion in your bet slip and wager $5+ cash on any market (min. odds -500) within 7 days of account opening to receive $100 in FanCash. Promotional FanCash expires 7 days from issuance (at 11:59pm ET). Terms, including FanCash terms apply-see Fanatics Sportsbook app. Use FanCash on bonus bets, profit boosts, team gear on Fanatics.com and so much more. ++++++ Timestamps: 0:00 YANKEES TRADED FOR LUIS GARCIA JR. 20:20 Camilo Doval Also Traded Away   22:10 Injury Updates 23:55 Yankees WIN Game 1 31:15 Yankees Lose Game 2 36:30 Yankees WIN Game 3 and the Series   43:35 Pride of the Yankees: Will Warren 45:30 Pride of the Yankees: Spencer Jones 52:15 Yankee MFer 1:00:15 Ali Sanchez Had a 3-Hit Day   1:04:15 Jose Caballero   1:08:55 Paul Goldschmidt   1:12:40 Angel Chivilli is Still Just Awesome? Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Welcome back to the Audible Bleeding Series: Landmark Papers in Vascular Surgery. In this episode, Audible Bleeding editor John Culhane and co-host Dr. Jesse Columbo are joined by our guests, Dr. David Stone, Dr. Salvatore Scali, and Dr. Anders Wanhainen to unpack one of the longest-running debates in aortic surgery: when (and whether) to repair an abdominal aortic aneurysm. We'll start our episode with the open-repair era and the two trials that set the basis for the 5.5 cm threshold—UKSAT and ADAM—then move into the early EVAR years with PIVOTAL and CAESAR, which asked whether fixing smaller aneurysms with endovascular technology could do better. Finally, we'll look at how modern screening programs, improved medical therapy, and current guidelines have reshaped the practical decisions we make for these patients every day.   Links to Papers Discussed: Open Surgery Era 1.    UKSAT (1998) 2.    ADAM (2002)    Endovascular Era 1.    PIVOTAL (2010) 2.    CAESAR (2012)    Contemporary Results 1.    Oliver-Williams/NHS NAAASP  2.    Rokosh/SVS Guidelines 3.    ESVS 2026 Guidelines   Guests: Dr. David Stone, MD (@DHStoneMD); Dartmouth Dr. Salvatore Scali, MD (@UFVascular); University of Florida Dr. Anders Wanhainen, MD, PhD (@AWanhainen); Uppsala University, Sweden   Hosts: John Culhane, MD (@JohnCulhaneMD); Vascular Surgery Fellow, Montefiore Dr. Jesse Columbo, MD; Dartmouth   Follow us @audiblebleeding,   Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey. *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

In this episode, Leanne Yanni, MD, MHCM, President and Chief Executive Officer, Illinois Physician Enterprise, Hospital Sisters Health System, discusses building a long-term strategy for physician growth, expanding access in rural communities and strengthening leadership across the organization. She also shares how ambient AI, team-based care and population health are helping improve clinician experience and patient outcomes.

In this episode, Jodi Skiles, MD, Medical Director of the Pediatric Stem Cell Transplant Program at Riley Hospital for Children in Indianapolis, joins the podcast to discuss a groundbreaking milestone in pediatric medicine—the world's first bone marrow stem cell transplant using cells from a deceased donor in a 14-year-old patient. She shares the significance of expanding access to this innovative donor source and how advances in transplant medicine are creating new opportunities to improve outcomes for children in need of life-saving care.

In this episode, Leanne Yanni, MD, MHCM, President and Chief Executive Officer, Illinois Physician Enterprise, Hospital Sisters Health System, discusses building a long-term strategy for physician growth, expanding access in rural communities and strengthening leadership across the organization. She also shares how ambient AI, team-based care and population health are helping improve clinician experience and patient outcomes.

In this April 2014 interview, Daniel Pastula, MD, MHS, EIS Officer & Neurologist with CDC's Arboviral Diseases Branch discusses the new Heartland virus disease with Outbreak News This Week Radio Show host Robert Herriman

VERY Unusual start for August, but Blind Hog and Acorn are not complaining.  After a few days of rain, the farmers were able to get out and about and start clearing brush and overhanging limbs on the west fence line.Blind Hog got his cataract evaluation and will be getting a new lens in mid August. Yay!  The MD used a laser and cleared crud from behind the replacement lens in his left eye, and it is now brighter!Guinea peeps have hatched from batch 1...  Six keets, but the unhatched keet that got thrown in the trash then found to still be alive is a bit slow,  not sure it it will make it.  We will see...

Whatever Happened to Sin? by Lighthouse Baptist Church | Williamsport, MD

Justin and Snacks react to Day 4 of Giants Training Camp!   Download the Fanatics Sportsbook app , use code JOMBOY https://fanatics.onelink.me/5kut/JOMBOY New customers who sign up and Bet $5, Get $100 in FanCash*. Use FanCash on bonus bets, profit boosts, team gear and more on Fanatics.com.   Check out our Merch: https://shop.jomboymedia.com/collections/talkin-giants   Subscribe to JM Football for our NFL coverage: https://www.youtube.com/@JMFootball   Follow along with Jomboy Media at theshownotes.jomboymedia.com   #giants #nygiants   *New customers in AZ, CO, CT, DC, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NY, OH, PA, TN, VA, VT, WV, or WY. Must toggle on this promotion in your bet slip and wager $5+ cash on any market (min. odds -500) within 7 days of account opening to receive $100 in FanCash. Promotional FanCash expires 7 days from issuance (at 11:59pm ET). Terms, including FanCash terms apply-see Fanatics Sportsbook app. Use FanCash on bonus bets, profit boosts, team gear on Fanatics.com and so much more. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Today, I am delighted to connect with Dr. Elisa Port, a talented breast surgeon with a passion for helping women better understand breast cancer, breast health, and the science behind screening, diagnosis, and treatment. She's the chief of breast surgery for Mount Sinai Health System in New York, a professor of surgery at Mount Sinai's Icahn School of Medicine, and the author of The Breast Advice. In our conversation, we explore breast cancer risk factors, various screening mechanisms and their impact on dense breasts, and the role of diagnosis and pathology, including DCIS. We also discuss menopause symptom management, anti-hormone and targeted treatments, immunotherapy, de-escalation, and why a personalized approach to breast cancer treatment is so important.  Stay tuned for a truly informative conversation with Dr. Port. With her infectious optimism, she has a wonderful way of translating the science and the research in her book, making it accessible and putting the statistics into context so the information feels far less scary than it otherwise might. IN THIS EPISODE, YOU WILL LEARN: How 90% of women diagnosed with breast cancer have no family cancer history How body weight and alcohol can influence breast cancer risk Why Dr. Port recommends annual mammograms beginning at age 40 for most women Dr. Port may disagree with recommendations against breast self-exams Why women with dense breasts may benefit from supplemental ultrasound or MRI in addition to mammography Unvalidated breast screening tests may lead to false positives, unnecessary testing, procedures, anxiety, and expense. What DCIS is, and how it influences treatment decisions Why an individualized approach is essential when using SERMs, SERDs, and aromatase inhibitors How Oncotype testing helps to identify women who may safely avoid chemotherapy Bio: Dr Elisa Port Dr. Elisa Port, MD, is chief of breast surgery at Mount Sinai Health System, which encompasses seven different breast centers. Her team performs over a thousand breast surgical procedures each year. She is also the director of the Dubin Breast Center, a state-of-the-art breast center in Manhattan that opened in April 2011. She personally consults with thousands of patients and performs hundreds of operations each year. Dr. Port is a trusted voice in the media and a sought-after speaker. She has been featured in The New York Times, NPR, CBS, Today, Mornings with Maria, and Pix11. In addition to her media presence, Dr. Port regularly speaks at public events and is invited to present at conferences and panels across the country. She lives in Manhattan with her husband and two dogs. Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. Elisa Port On her website On her personal Instagram  Breast Advice MD on Instagram The Breast Advice Substack

In this episode, David N. Bernstein, MD, PhD, MBA, MEI, Harvard Orthopaedic Surgeon, shares his perspective on the future of orthopedic care, discussing value-based healthcare, ambulatory surgery centers, AI, and why measuring the outcomes that matter most to patients will shape the next generation of care delivery.

Outsmarting Cancer: Risk Reduction and the Power of Prevention (Johns Hopkins University Press, 2026) reframes one of the most pressing medical challenges of our time: how to prevent cancer. In this timely and accessible book, physician and medical researcher Adam Barsouk, MD, presents a sweeping examination of cancer's true origins-biological, environmental, dietary, infectious, industrial, occupational, and behavioral-and makes a compelling case for why cancer prevention must become a central priority in public and personal health. With personal stories from his clinical practice and the latest research, Dr. Barsouk explains why more people are getting diagnosed with cancer-and at younger ages-than ever before. This book explores a wide range of overlooked and misunderstood risk factors, as well as how inequities in diagnosis, treatment, and prevention disproportionately impact underserved populations. Unlike typical cancer books that focus narrowly on diet or organ-specific disease, Outsmarting Cancer takes a comprehensive, systems-level view, urging readers to look beyond the symptoms and target the root causes. Dr. Barsouk explores the role of genetic predisposition to cancer alongside environmental, lifestyle, and public policy influences that may contribute to developing the disease. With rigorous scientific insight, he offers real-world, evidence-based strategies to reduce cancer risk in practical, meaningful ways. Honest, urgent, and empowering, Outsmarting Cancer challenges readers to rethink how we talk about cancer and how we can reduce its burden before it begins. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Can artificial intelligence restore humanity to my patient interactions? In this episode, Dr May Lin and Dr Brent Sugimoto explore how ambient scribing and smarter administrative tools free physicians to be truly present with their patients, allowing technology to become a bridge in patient care rather than a barrier. Our guests also tackle the ethical and policy dimensions of how AI affects family medicine in both the exam room and the classroom. They identify the current moment as an opportunity for residency programs to shape how AI is used in family medicine, emphasizing that if today's residents are not trained to use AI tools ethically and wisely, their future patients may miss out on the benefits of technology-assisted care.Hosted by Omari A. Hodge, MD, FAAFP and Jay-Sheree Allen Akambase, MDCopyright © Society of Teachers of Family Medicine, 2026Resources:Blood in the Machine: The Origins of the Rebellion Against Big Tech by Brian MerchantArtificial Intelligence and Machine Learning for Primary Care Curriculum (AiMPC) CourseEthical Use of AI in the Family Medicine Clinic - STFM WebinarAn Opportunity to Thrive - AI in Family Medicine - STFM PodcastAI Deep Dive Summer Series Episode 1: Integrating AI into Family Medicine Curriculum Design - STFM PodcastAI Deep Dive Summer Series Episode 2: The Promises and Pitfalls of AI in Residency Assessment - STFM PodcastGuest Bio:May Lin, DODr Lin is board certified in Family Medicine and Osteopathic Manipulative Medicine (OMM). She practices at Amazon/One Medical where she also serves as the Director of Academic Development. A graduate of Harvard Medical School's Executive Education Course on AI in Healthcare, Dr. Lin serves on the American Association of Colleges of Osteopathic Medicine's (AACOM) Technology Task Force, Touro University's AI Task Force, and the American Osteopathic Information Association's (AOiA) national steering committee. As an Osteopathic Health Policy Fellow, Dr. Lin blends policy interest with leadership experience in healthcare technology and medical education. Dr. Lin is passionate about advancing medical innovation giving patients increased access, decrease cost and improved quality in high touch, technology forward medical care. Integrating primary care, medical innovation, healthcare technology, and healthcare policy are key attributes to supporting primary care and elevating our next generation for sustainable primary care practice and delivery.Brent Sugimoto, MD, MPHDr Sugumoto is program director of the LifeLong Medical Care Family Medicine Residency Program and a Family Physician who specializes in HIV medicine. He currently serves as co-chair of the AAFP/Rock Health “Advancing AI and Digital Health for Primary Care Initiative.” Brent ventured into artificial intelligence after the birth of his first child—when parenthood made him rethink the boundaries of his professional and personal lives—and co-founded a startup called Decoded Health, which leveraged technology from DARPA to build tools to make primary care sustainable. Since then, Brent has worked to increase family medicine's engagement in AI/ML as a potentially transformative and disruptive technology through physician education and policy work within the specialty. Brent is excited to be a member of this task force, as he believes health technology literacy will be a critical competency for future family physicians. He uses ambient scribing with moderate success in his own practice.Link:https://www.stfm.org/stfmpodcast082026 

Justin and Snacks react to Day 3 of Giants Training Camp! Download the Fanatics Sportsbook app , use code JOMBOY https://fanatics.onelink.me/5kut/JOMBOY New customers who sign up and Bet $5, Get $100 in FanCash*. Use FanCash on bonus bets, profit boosts, team gear and more on Fanatics.com.  0:00 Defense Dominates: New York Giants Training Camp Recap 3 02:00 Every minute of practice matters with Harbaugh 06:15 Arvell Reese flying in practice 08:58 Abdul Carter is going to be in DPOTY Conversation 12:30 Offense was sloppy 16:30 Ar'Darius Washington competing and playing fast 21:30 Colton Hood got picked on 23:05 Fields is looking like WR2 25:50 Offensive struggles 27:16 Braxton Berrios making a case to earn a spot on the roster 28:50 Francis Mauigoa powerful handwork 31:30 OBJ is Quiet 31:50 Kicker battle update 33:30 Who is looking impressive 35:00 Should we be worried about the offense 38:00 What's the split with Tracy and Skattebo Check out our Merch: https://shop.jomboymedia.com/collections/talkin-giants Subscribe to JM Football for our NFL coverage: https://www.youtube.com/@JMFootball Follow all of our content on https://jomboymedia.com #giants #nygiants  *New customers in AZ, CO, CT, DC, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NY, OH, PA, TN, VA, VT, WV, or WY. Must toggle on this promotion in your bet slip and wager $5+ cash on any market (min. odds -500) within 7 days of account opening to receive $100 in FanCash. Promotional FanCash expires 7 days from issuance (at 11:59pm ET). Terms, including FanCash terms apply-see Fanatics Sportsbook app. Use FanCash on bonus bets, profit boosts, team gear on Fanatics.com and so much more. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Justin and Shaun react to Malik Nabers to start Giants training camp and talk about the biggest storylines coming out of camp Download the Fanatics Sportsbook app , use code JOMBOY https://fanatics.onelink.me/5kut/JOMBOY New customers who sign up and Bet $5, Get $100 in FanCash*. Use FanCash on bonus bets, profit boosts, team gear and more on Fanatics.com.  Get $15 off your first task at https://www.taskrabbit.com with promo code GIANTS. 0:00 Live from Giants Training Camp 01:35 Malik Nabers is looking GOOD 08:32 Nabers maturity in his recovery process 10:50 Takeaways from Dart so far 13:20 Growing Darts game 17:30 Receivers that Dart is leaning on 19:20 Fields finding ways to win 21:30 Darnell Mooney leading WR2 23:56 OL/DL run down 25:40 what are they doing with J.C. Davis 29:15 Need to see OBJ do well 30:05 Abdul Carter ready to be an elite pass rusher 32:00 How the Secondary is looking 36:00 Arvell Reese quiet to start camp 39:20 Kicking competition 41:40 Justin Tucker whispers among the beat writers 44:22 Harbaughs strict rules at camp 48:00 Thoughts on camp in WV 54:00 Training camp under Harbaugh 55:30 Fanatics Fivo, top 5 interception leaders in 2026 Check out our Merch: https://shop.jomboymedia.com/collections/talkin-giants Subscribe to JM Football for our NFL coverage: https://www.youtube.com/@JMFootball Follow all of our content on https://jomboymedia.com #giants #nygiants  *New customers in AZ, CO, CT, DC, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NY, OH, PA, TN, VA, VT, WV, or WY. Must toggle on this promotion in your bet slip and wager $5+ cash on any market (min. odds -500) within 7 days of account opening to receive $100 in FanCash. Promotional FanCash expires 7 days from issuance (at 11:59pm ET). Terms, including FanCash terms apply-see Fanatics Sportsbook app. Use FanCash on bonus bets, profit boosts, team gear on Fanatics.com and so much more. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Industrial Talk is onsite at MD&M West and talking to Matt Bishop, Head of Global Sales at VATIT STREAM about "International Logistics Compliance". The Industrial Talk podcast, sponsored by MD&M West and News and Brews, features Scott Mackenzie discussing the importance of industrial innovation and celebrating industry professionals. At MD&M West in Anaheim, California, Scott interviews Matthew Bishop, the head of sales at VATIT STREAM, a company specializing in VAT efficiency and logistics compliance. Bishop explains how VATIT STREAM helps manufacturers navigate tariffs and VAT, particularly for medical manufacturers, by setting up foreign entities and handling logistics. They discuss the complexities of international trade, the importance of compliance, and the benefits of their services in simplifying global shipments. Bishop also shares his experience attending the conference and the challenges of international travel. Outline MD&M West Conference Introduction Scott introduces the episode of Industrial Talk, sponsored by MD&M West and News and Brews, highlighting the innovation and energy at the conference.Scott celebrates industry professionals for their boldness, bravery, and problem-solving skills, encouraging them to share their achievements with their families.The podcast is broadcasting live from MD&M West in Anaheim, California, with Speaker 1 inviting listeners to mark their calendars for the next event in 2027. Introduction of Matthew Bishop Scott introduces Matthew Bishop, also known as Matt, and mentions the challenges and innovations in the manufacturing industry.Matt shares his experience at the conference, mentioning the physical activity involved and the opportunity to connect with industry peers.Matt reveals he is based in Johannesburg, South Africa, and discusses the long flight to attend the conference.Scott and Matt exchange light-hearted comments about South African food, with Matt explaining traditional dishes like boerewors and koeksisters. Matthew Bishop's Background and Role Matt provides a background on himself, mentioning his role as the head of sales for VATIT STREAM and his experience in tech sales.Scott and Speaker 3 discuss the complexity of VAT and its impact on manufacturers, with Speaker 3 explaining the challenges of tariffs and HS codes.Matt elaborates on the services provided by VATIT STREAM, including setting up foreign entities and handling logistics and compliance.Scott asks about the process of setting up a foreign entity in the USA, and Speaker 3 explains the steps involved, including registration and handling customs. VATIT STREAM's Services and Solutions Matt explains how VATIT STREAM helps manufacturers navigate tariffs and VAT, emphasizing the importance of correct HS codes.Matt discusses the company's global presence with offices in the USA, UK, Netherlands, and South Africa, and their ability to handle logistics for various industries.Matt highlights the benefits of setting up as a foreign entity, including avoiding sales tax and the ability to claim VAT back.Scott and Matt discuss the challenges of logistics and compliance, with Speaker 3 emphasizing the importance of having experts to handle these complexities. Future of Logistics and Manufacturing Scott asks about the future of logistics and manufacturing, and Speaker 3 expresses skepticism about a quick resolution to the current challenges.Matt discusses the ongoing changes in laws and regulations, and the need for continuous adaptation and innovation in the logistics industry.Scott and Matt agree on the importance of efficient and cost-effective supply chain management for manufacturing success.Matt provides contact information for listeners interested in learning more about VATIT STREAM and its services. Closing Remarks and Event Promotion Scott wraps up the conversation, expressing gratitude to Matthew Bishop for his insights and contributions to the podcast.Scott promotes the MD&M West event, encouraging listeners to mark their calendars for the next event in 2027.Scott highlights the importance of the event in showcasing innovation and connecting industry professionals.The podcast concludes with a reminder to stay tuned for future episodes and to reach out to Matthew Bishop for more information on VATIT STREAM. If interested in being on the Industrial Talk show, simply contact us and let's have a quick conversation. Finally, get your exclusive free access to the Industrial Academy and a series on “Why You Need To Podcast” for Greater Success in 2026. All links designed for keeping you current in this rapidly changing Industrial Market. Learn! Grow! Enjoy! MATTHEW BISHOP'S CONTACT INFORMATION: Personal LinkedIn: https://www.linkedin.com/in/matt-bishop-stream/ Company LinkedIn: https://www.linkedin.com/company/vatitstream/ Company Website: https://www.vatitstream.com/ PODCAST VIDEO: https://youtu.be/Tpo4VtkLoFU THE STRATEGIC REASON "WHY YOU NEED TO PODCAST": OTHER GREAT INDUSTRIAL RESOURCES: NEOM: https://www.neom.com/en-us Hexagon: https://hexagon.com/ Arduino: https://www.arduino.cc/ Fictiv: https://www.fictiv.com/ Hitachi Vantara: https://www.hitachivantara.com/en-us/home.html Industrial Marketing Solutions:  https://industrialtalk.com/industrial-marketing/ Industrial Academy: https://industrialtalk.com/industrial-academy/ Industrial Dojo: https://industrialtalk.com/industrial_dojo/ We the 15: https://www.wethe15.org/ YOUR INDUSTRIAL DIGITAL TOOLBOX: LifterLMS: Get One Month Free for $1 – https://lifterlms.com/ Active Campaign: Active Campaign Link Social Jukebox: https://www.socialjukebox.com/ Industrial Academy (One Month Free Access And One Free License For Future Industrial Leader): Business Beatitude the Book Do you desire a more joy-filled, deeply-enduring sense of accomplishment and success? Live your business the way you want to live with the BUSINESS BEATITUDES...The Bridge connecting sacrifice to success. YOU NEED THE BUSINESS BEATITUDES! TAP INTO YOUR INDUSTRIAL SOUL, RESERVE YOUR COPY NOW! BE BOLD. BE BRAVE. DARE GREATLY AND CHANGE THE WORLD. GET THE BUSINESS BEATITUDES! Reserve My Copy and My 25% Discount

Another failure of LA posterior wall isolation, first-line AF ablation, a revelation on EAST-AFNET 4 trial, an LAAC meta-analysis, and preventing AKI post-cardiac surgery are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback DAPT-MVD Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2517588 II Another Failure of Posterior Wall Isolation CORNERSTONE-AF Trial https://doi.org/10.1093/eurheartj/ehag486 CAPLA Trial https://jamanetwork.com/journals/jama/fullarticle/2800186 PVIOTAL IDE Trial 10.1016/j.hrthm.2025.08.018 External Link III First Line AF ablation – One new study and a discovery about a second one Catheter Ablation vs AAD for First-line Treatment of AF 10.1016/j.hrthm.2025.07.061 External Link EAST-AFNET 4 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2019422 Cardiology Trials Substack https://cardiologytrials.substack.com/p/summary-and-discussion-of-east-afnet IV Left Atrial Appendage Closure Meta-analysis Long-Term Efficacy and Safety of LAAC vs OAC -- Meta-analysis https://academic.oup.com/europace/article/28/7/euag159/8739567 V Prevention of AKI after Cardiac Surgery: MERCURI-2 MERCURI-2 Study https://jamanetwork.com/journals/jama/fullarticle/2852324 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

GAMBLING PROBLEM? CALL 1-800-GAMBLER or 1-800-MY-RESET, 800-327-5050/visit gamblinghelplinema.org (MA). Call 888-789-7777/visit ccpg.org (CT), mdgamblinghelp.org (MD), 800-981-0023 (PR). Wagering offered by DK Sportsbook: 21+. Present in most states. (18+ DC/NH/PR/WY). Void in CAN. On behalf of Boot Hill Casino (KS). Pass-thru of per wager tax may apply in IL. Event Trading offered by DraftKings Predictions, CFTC-registered: 18+. Trading involves risk of loss. Market availability varies. General: 1 per new DraftKings customer. $5+ deposit req. Trade $5 get $150 Prediction Dollars (1-year expiry); or bet $5 get $150 in Bonus Bets (7-day expiry and stake removed from payout). Rewards issued in $50 increments every 7 days via click-to-claim for 14 days. Predictions Dollars click-to-claims expire 7 days after issuance. Rewards are non-withdrawable. 7 days = 168hrs. Predictions offer void in NY. Terms: dkng.co/offer. Ends 8/23/26 at 11:59 PM ET. Sponsored by DK.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/wegottabelieve

Hear the latest on blood-based biomarkers, lifestyle interventions, and more from AAIC 2026 with Gil Rabinovici, MD. Related Content: Soccer Players' Brains, P-Tau217 Blood Tests, Lifestyle and Dementia Risk, and More From AAIC 2026

In today's episode, we welcomed Douglas W. Sborov, MD, MS, to discuss the significance of the July 2026 FDA approval of isatuximab-irfc (Sarclisa Escena) for subcutaneous injection for multiple myeloma indications. Dr Sborov is a tenured professor of medicine in the Department of Internal Medicine in the Division of Hematology and Hematologic Malignancies and an adjunct associate professor in the Departments of Molecular Pharmaceutics and Biomedical Engineering at the University of Utah Huntsman Cancer Institute (HCI) in Salt Lake City, as well as director of the HCI Hematology Disease Center and Plasma Cell Dyscrasias (PCD) Program, co-leader of the Hematologic Malignancies Clinical Trials Research Group, and member of the HCI Experimental Therapeutics Program and International Myeloma Working Group (IMWG).As part of the July 10, 2026, approval, subcutaneous isatuximab is indicated for use: in combination with pomalidomide (Pomalyst) and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least 1 prior line of therapy, including lenalidomide (Revlimid) and a proteasome inhibitor in combination with carfilzomib (Kyprolis) and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received 1 to 3 prior lines of therapy in combination with bortezomib (Velcade), lenalidomide, and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are not eligible for an autologous stem cell transplant In our exclusive interview, Dr Sborov outlined how the subcutaneous formulation of isatuximab and the ability to administer the agent via an on-body delivery system could affect patient quality of life. He also detailed key findings from the phase 3 IRAKLIA trial (NCT05405166) that supported the approval and explained how the use of isatuximab may shift in clinical practice following the subcutaneous approval.

In today's episode, we spoke with Solange Peters, MD, PhD. Dr Peters is a full professor, and chair of medical oncology and the thoracic malignancies programme in the Department of Oncology at the University Hospital of Lausanne in Switzerland. In our exclusive interview, Dr Peters discussed the rationale for pairing antiangiogenic activity with checkpoint inhibition upfront in non–small cell lung cancer (NSCLC), rather than sequencing them. She noted that prior attempts to combine or sequence bevacizumab (Avastin) with checkpoint inhibitors yielded only modest signals, hampered by bevacizumab's long half-life and class-specific toxicities including bleeding risk that historically excluded patients with squamous cell carcinoma. By contrast, PD-L1/VEGF bispecifics such as pumitamig carry a significantly shorter half-life of approximately 5 to 6 days, resulting in a similar toxicity category but with lower rates of high-grade events and a broadened eligible population.She highlighted the mechanistic rationale for this combination, explaining that VEGF and PD-L1 co-targeting appears to remodel the tumor microenvironment cooperatively, bringing cancer cells into closer proximity with T cells. In the case of PD-L1/VEGF bispecifics, a macromolecular structure forms in the tumor microenvironment that leads to internalization of PD-L1, creating a dual blockade of the PD-1/PD-L1 pathway beyond simple receptor occupancy.Dr Peters then discussed data presented at the 2026 ASCO Annual Meeting from the phase 2/3 ROSETTA Lung-02 trial (NCT06712316) evaluating pumitamig plus chemotherapy in the first-line setting. She described the activity observed across all PD-L1 expression strata, including in PD-L1–negative patients, who comprised up to 70% of the nonsquamous population and achieved response rates above 50% as particularly compelling. She also addressed the dose selection rationale, noting that the 1500-mg dose demonstrated the optimal pharmacodynamic activity and favorable risk-benefit profile for phase 3 advancement.Finally, Dr Peters offered broader perspective on the increasingly competitive PD-L1/VEGF bispecific landscape, including the parallel development of ivonescimab. She suggested that differences in clinical trial design including patient population, inclusion and exclusion criteria, and end point ambition may ultimately differentiate agents more than mechanism alone, and emphasized that global data will be essential to shaping regulatory and clinical practice decisions.

Editor's Summary by Linda Brubaker, MD, and Christopher C. Muth, MD, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from July 25-31, 2026.

Editor's Choice:  Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 updateEditorial: The evolving landscape of personalized perioperative care: A commentary on the 2026 ERAS® Gynecologic oncology guidelinesHosted by: Sean C. Dowdy, MD; Division of Gynecologic Oncology, Mayo Clinic College of Medicine, Rochester, MN, USAFeaturing: Gregg Nelson, MD, PhD; Department of Obstetrics & Gynecology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaRichard D. Urman, MD; Department of Anesthesiology, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, OH, USAOlle Ljungqvist, MD, PhD; Department of Molecular Medicine & Surgery, Karolinska Institutet, Stockholm, SwedenCheck out more content on the journal's homepage  at https://www.gynecologiconcology-online.net

Send us Fan Mail"It is probably nothing."The swelling is probably the third trimester. The breathlessness is probably the stairs. The ache in your calf is probably that run you should not have done. And most of the time, all of that is exactly right.Most of the time is doing a lot of work in that sentence.Dr. Rachel Rosovsky is a hematologist at Massachusetts General Hospital, where she has spent twenty years on blood clots, and she co-authored the first ever AHA/ACC guideline on acute pulmonary embolism. The American Heart Association reached out about this one, and I said yes immediately, because this is the conversation I do not think most of us have ever actually had.

Send Audrey a Text to get your question answered on the showPalmitoylethanolamide, better known as PEA, is gaining attention as a potential tool for chronic, inflammatory, and neuropathic pain. In this episode, Audrey examines how PEA works, the only published equine case series, the dose used in those horses, formulation and absorption concerns, safety limitations, where PEA might fit in a rehabilitation plan, and why FEI competitors need to be extremely cautious.This one is a doozy! Stay with me until the end for summary information. Minerals and Metals Mane Test: https://equine-energy-medicine.myshopify.com/products/minerals-and-metals-mane-test?variant=66748496150832Find all the resources listed here: linktr.ee/equineenergymedAudrey is not an MD or DVM and has never implied or claimed to be either. Audrey holds a Doctoral Degree of Traditional Naturopathy and a Masters Degree in Science. She created an evidence-based anti-inflammatory nutrition program for equines and has successfully helped over 10k horses with a balanced anti-inflammatory forage diet. This information is non-medical in nature and is not meant to diagnose, prescribe for, treat, or cure, and is not a replacement for your veterinarian.  These are my personal interpretations based on my education, skills, and experience. Equine Energy Medicine refers to non-invasive, supportive modalities focused on energetic balance, nutrition, and overall well-being, and does not replace veterinary care.

Snigdha Kalidindi, MD, Sports Medicine at Riverside Healthcare, reviews common fall sports injuries, explains step‑by‑step prevention, and when to take action.  Learn more about Dr. Kalidindi 

"I'm starstruck every time I'm at a track meet and I get to be side by side with some of these incredible athletes. That has not worn off and I don't think it ever will. And I hope it never does." It's been a few years since Jay Holder has been on the Ali on the Run Show, and today he returns as USA Track & Field's Chief Content & Communications Officer. Jay talks about how he got the job a year ago, what the first year in the role has been like, and what impact he hopes to have on the organization, the sport, the athletes, and beyond. He reflects on his time going from New York City newsrooms to the Atlanta Track Club to being Executive Director of Running USA, and shares his advice for people looking to break into the running industry. Plus, his recap from this year's U.S. National Championships at Icahn Stadium in New York City, including what it took to get New York City Mayor Zohran Mamdani at the meet, and what it was like once he was on site. Jay lives in Severna Park, MD, with his wife, Lauren, and their two children. SPONSORS:  Lagoon. My favorite pillows and pillowcases! Click here to get the limited edition Ali on the Run x Lagoon Cool Flex Performance Pillowcase (!!!), and use code ALI at checkout for 15% off. Vuori: Click here for 20% off your first Vuori purchase. Oofos: The best in the recovery footwear game. Click here to check out Oofos's new CLUB+ line! Your feet are going to be so happy! IN THIS EPISODE: What's making Jay happy today, and how he found his local running group (3:20) Jay shares his take on running streaks — including one of his own — and what's next on his race calendar (8:20) The books, music, movies, and TV shows Jay is into right now (12:40) Jay's lows from 2026 USAs (19:40) What was the main feedback  or critique from this year's USAs? (23:30) Jay's highlights from USAs, and how they got NYC Mayor Zohran Mamdani at the meet (28:00) On racing the New York Road Runners Team Championships 5-miler in Central Park during the meet weekend (41:00) Who are the biggest stars in our sport right now? (45:35) How Jay got the job as USATF CCCO (50:30) What impact does Jay want to have on the sport? (56:30) What does a Chief Content & Communications Officer do? (1:04:30) On being starstruck at work (1:07:00) What will LA 2028 look like for Jay? (1:13:00) Jay's advice for people who want to work in the running industry (1:19:50) On Jay's recent health diagnoses, and how he has processed them (1:23:45) Follow Ali: Instagram @aliontherun1 Subscribe to the newsletter Join the Facebook group Support on Patreon SUPPORT the Ali on the Run Show! If you're enjoying the show, please subscribe and leave a rating and review on Apple Podcasts. Spread the run love. And if you liked this episode, share it with your friends!

This episode is brought to you by our official Yankees merch collection! Shop NOW for 10% off: https://shop.jomboymedia.com/discount/TY73010OFF?redirect=/collections/yankees-mlb&utm_source=youtube&utm_medium=video&utm_campaign=TY73010OFF Find out how baseball hits different with T-Mobile at https://www.T-Mobile.com/MLB   Use code JOMBOY for up to 44% off your next Create order: https://trycreate.co/discount/JOMBOY?redirect=/pages/jomboy&utm_source=podcast&utm_medium=partnership&utm_campaign=jomboymedia&utm_content=Talkin-Yanks Sponsored by Create. Download the Fanatics Sportsbook app , use code JOMBOY https://fanatics.onelink.me/5kut/JOMBOY New customers who sign up and Bet $5, Get $100 in FanCash*. Use FanCash on bonus bets, profit boosts, team gear and more on Fanatics.com. *New customers in AZ, CO, CT, DC, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NY, OH, PA, TN, VA, VT, WV, or WY. Must toggle on this promotion in your bet slip and wager $5+ cash on any market (min. odds -500) within 7 days of account opening to receive $100 in FanCash. Promotional FanCash expires 7 days from issuance (at 11:59pm ET). Terms, including FanCash terms apply-see Fanatics Sportsbook app. Use FanCash on bonus bets, profit boosts, team gear on Fanatics.com and so much more. ++++++ Timestamps: 0:00 Mini State of the Union 6:05 Injury Updates   8:30 Yankees Win an INTERESTING Game 1   15:10 Yankees WIN Game 2! 23:25 Yankees Blew Game 3 in Extras   37:20 Yankees Blew ANOTHER Extra Inning Game 44:40 Pride of the Yankees: Gerrit Cole 46:30 Pride of the Yankees: Cam Schlittler 49:15 Yankee MFer 56:20 Ryan Weathers Had a GREAT Start Too   59:00 Fernando Cruz Was Good 1:03:40 Spencer Jones Should Play More 1:09:30 Jasson Dominguez WEIRD Season 1:22:10 Cubs Series Preview Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Justin and Snacks react to Day 2 of Giants Training Camp!  Download the Fanatics Sportsbook app , use code JOMBOY https://fanatics.onelink.me/5kut/JOMBOY New customers who sign up and Bet $5, Get $100 in FanCash*. Use FanCash on bonus bets, profit boosts, team gear and more on Fanatics.com.  0:00 Day 2 Giants Training Camp Recap 03:20 Wrinkles in the offense 08:30 More efficient practices with Harbaugh 12:30 Dart connecting with Likely 14:50 Malachi Fields surefire hands 17:30 How OBJ looks 19:50 Arvell Reese lining up 21:15 how the rookies looked 25:00 Kayvon standing out 29:30 Wrinkles on the Defense 31:55 Malik Nabers update 33:15 Kicker Battle 33:30 Defense jawing at the offense 35:48 Leki Fotu 37:20 Hot Dog tradition Check out our Merch: https://shop.jomboymedia.com/collections/talkin-giants Subscribe to JM Football for our NFL coverage: https://www.youtube.com/@JMFootball Follow all of our content on https://jomboymedia.com #giants #nygiants  *New customers in AZ, CO, CT, DC, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NY, OH, PA, TN, VA, VT, WV, or WY. Must toggle on this promotion in your bet slip and wager $5+ cash on any market (min. odds -500) within 7 days of account opening to receive $100 in FanCash. Promotional FanCash expires 7 days from issuance (at 11:59pm ET). Terms, including FanCash terms apply-see Fanatics Sportsbook app. Use FanCash on bonus bets, profit boosts, team gear on Fanatics.com and so much more. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On this weeks episode, Large, Spider, and Quigs, and Moonhead breakdown this last weekend in NASCAR at Indianapolis and discuss what's to come this next week in Iowa. Corey Heim joins the show to breakdown his thoughts for the rest of the season. Thanks for watching! Huge thank you to our sponsors: BODYARMOR: Work hard and hydrate hard with BODYARMOR Flash I.V. Grab it at 7-Eleven CUERVO: From the first lap till the checkered flag, there's only one choice. Keep It Cuervo.  SHADY RAYS: Go to http://shadyrays.com and use code RUBBIN for 50% off 2+ pairs of polarized sunglasses. BLUECHEW: Visit https://BlueChew.com for more details and important safety information.  DRAFTKINGS: GAMBLING PROBLEM? CALL 1-800-GAMBLER or 1-800-MY-RESET, 800-327-5050/visit gamblinghelplinema.org (MA). Call 888-789-7777/visit ccpg.org (CT), mdgamblinghelp.org (MD), 800-981-0023 (PR). Wagering offered by DK Sportsbook: 21+. Present in most states. (18+ DC/NH/PR/WY). Void in CAN. On behalf of Boot Hill Casino (KS). Pass-thru of per wager tax may apply in IL. Event Trading offered by DraftKings Predictions, CFTC-registered: 18+. Trading involves risk of loss. Market availability varies. General: 1 per new DraftKings customer. $5+ deposit req. Trade $5 get $150 Prediction Dollars (1-year expiry); or bet $5 get $150 in Bonus Bets (7-day expiry and stake removed from payout). Rewards issued in $50 increments every 7 days via click-to-claim for 14 days. Predictions Dollars click-to-claims expire 7 days after issuance. Rewards are non-withdrawable. 7 days = 168hrs. Predictions offer void in NY. Terms: dkng.co/offer. Ends 8/23/26 at 11:59 PM ET. Sponsored by DK.

In this episode of the Behind the Knife Global Surgery Series, we take a closer look at the real-world complexity of global surgery partnerships between high-income institutions and partners in the Global South. Words like equity, bidirectionality, partnership, and decolonization are used often in global surgery—but what do they actually mean when funding, mobility, research access, publication opportunities, and institutional power are unequally distributed?Host Mike Mallah is joined by Dr. Hugo Stark from George Hospital in South Africa and Dr. Sydney Bertram from Emory for a candid discussion about the benefits and tensions of collaborations in an unequal world. Together, they explore how global surgery partnerships can create meaningful educational and clinical value, how good intentions can still reproduce unequal systems, and how surgeons can build partnerships that are locally useful, honest about power, and ultimately centered on better surgical care for patients.Hosts/Guests:- Mike M. Mallah, MD, FACS, FICSDirector of Global Surgery at Medical University of South Carolina@MikeMMallahMD@MUSCGlobalSurgmallahm@musc.edu- Hugo Stark, MDHead of Department - Surgery, George Hospital, Western Cape, South AfricaHead of Surgical Services, Central Karoo RegionSydney Bertram, MDGeneral Surgery Resident, Emory UniversityTrainee Advisory Council, Consortium of Universities for Global Health@Sydney_Bertram Learning objectives:• Describe how global surgery partnerships can provide educational, clinical, professional, and research value for both high-income and Global South partners.• Identify how asymmetries in funding, mobility, publication access, and institutional agenda-setting can create inequity within otherwise well-intentioned global surgery partnerships.• Discuss practical principles for ethical global surgery engagement, including centering local needs, avoiding extraction, building durable partnerships, and focusing on patient access to surgical decision-making.Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewOBGYN Oral Board Review Coures: https://behindtheknife.org/course/obgyn-oral-board-reviewEPA Playbook: https://behindtheknife.org/course/epa-playbookSurgical Instrument Flashcards: https://behindtheknife.org/course/surgical-instrument-flashcardsABSITE Review: https://behindtheknife.org/course/absite-2026-exam-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Covid and the banality of evil. Most people assumed Tony Fauci was either a brilliant scientist or an evil mastermind, or maybe both. His diary reveals he's just a vain teenage girl pining for cable news hits. Mary Talley Bowden, MD, is a Houston-based, Stanford-trained otolaryngologist. During the COVID-19 pandemic she became a prominent advocate for early outpatient treatments and greater healthcare transparency, positions that placed her in open conflict with major medical institutions. She is the author of Dangerous Misinformation: The Virus, the Treatments, and the Lies. Paid partnerships with:Angel Studios: Watch the Charlie Kirk Documentary at http://angel.com/carlson American Financing: NMLS 182334, nmlsconsumeraccess.org. APR for rates in the 5s start at 6.327% for well qualified borrowers. Call 800-685-5696 for details about credit costs and terms. Visit http://www.AmericanFinancing.net/Tucker. Mars Men: For a limited time, our listeners get 50% off FOR LIFE, free shipping, AND 3 free gifts at Mars Men at MenGoToMars.comTCN: Watch ‘The World Is Watching You' only on https://tuckercarlson.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Philip Ovadia, MD, is a board-certified heart surgeon who became a leading advocate for metabolic health after confronting both his patients' outcomes and his own struggle with obesity and insulin resistance. With decades of surgical experience, he has witnessed firsthand the consequences of metabolic disease. Today, he focuses on prevention, education, and empowering individuals to reverse metabolic dysfunction before surgery becomes necessary. Founder of Ovadia Heart Health and host of The Stay Off My Operating Table Podcast. BUY THE BOOK!  Stay Off My Kitchen Table can be purchased here: https://stayoffmykitchentable.com/ Instagram: https://www.instagram.com/ifixhearts/ Facebook: https://www.facebook.com/ifixhearts YouTube: https://www.youtube.com/@UCu8xppo0Y7mJz4uqkc7o7TQ  Apple Podcasts: https://podcasts.apple.com/ca/podcast/stay-off-my-operating-table/id1587212660 Timestamps: 00:00 Trailer 01:11 Introduction 03:27 Interest in cardiac surgery and metabolic health 07:35 Healthcare system restrictions on doctors 12:31 Cardiac diet and post-surgery care 15:28 Book release and diet exploration 19:54 Moving to Florida and health insights 22:53 Controversial PCSK9 trial results 26:09 Challenges in understanding cholesterol 30:19 Discussing heart disease diagnoses 31:33 Importance of arterial plaque screening 37:26 Heart attacks and undiagnosed diabetes 39:13 Understanding CAC score progression 44:38 Discussing blood pressure guidelines 46:40 Where to find Dr. Ovadia Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.

In this episode of the Psychedelic Medicine Podcast, Alexander Lebedev, MD, PhD joins to discuss psychedelic medicine and psychosis. Dr. Lebedev is a physician-scientist, medical AI engineer, and entrepreneur working at the frontier of health and technology. His work spans collective societal dynamics, psychedelics, and medical AI; he leads Lebedev Labs and is co-founder of Dreamseer and Once Wellbeing Center. In this conversation, Dr. Lebedev explores the complex relationship between psychedelics and psychosis, examining what decades of research—and more recent clinical evidence—actually tell us about the risks. He explains why individuals with personal or family histories of psychotic disorders are typically excluded from clinical trials, clarifies the distinction between transient psychotic experiences and chronic psychotic disorders, and discusses why current evidence has not established a causal link between psychedelic use and persistent psychosis in screened populations. Throughout the discussion, Dr. Lebedev emphasizes the importance of careful screening, preparation, integration, and context, arguing that psychedelics should be understood through both scientific and phenomenological lenses rather than simplistic assumptions about safety or danger.   In this episode, you'll hear: What inspired Dr. Lebedev to study psychedelics and psychosis Why psychedelics became associated with psychosis and how that perception developed historically Why case reports of psychotic episodes following psychedelic use are not definitive to establish a causal link between the two How the lenses and frameworks we employ can significantly color how we understand psychosis and altered states of consciousness The role of set, setting, sleep, substance use, and integration in reducing psychological risks How psychedelic experiences overlap with—and differ from—psychotic states from a phenomenological perspective The intersection of psychosis and bipolar disorder and the relevance of this overlap to psychedelic medicine Why researchers are beginning to reconsider whether certain psychosis-spectrum populations should eventually be studied under carefully controlled conditions   Quotes: "The first framework within which psychedelics were studied and considered was the psychotomimetic framework, meaning that they were considered as tools that are supposed to mimic psychotic states." [9:22] "In the pre-prohibition era, psychedelics were tested on very large populations of different patients—including people with psychosis spectrum disorders, including people with schizophrenia spectrum disorders—with some mixed results. But there was already some data indicating that from a populational perspective, from a statistical link, we didn't have clear indication, even back then, that that link [between psychedelics and psychosis] exists." [12:48]  "Interestingly, unlike for cannabis, for tobacco, for some other substances, this link [with psychosis] was not verified in these large studies for psychedelics." [15:54] "If the only lens that you have is pathology, you can pathologize transformation as well. On the other hand, if the only lens that you have is spirituality, you can spiritualize the compensation that can come with the psychotic experience." [20:21] "From a phenomenological perspective, there are, of course, clear similarities [between psychedelic experiences and psychosis] . But of course, the background, the emotional content is very different. … If you read sometimes descriptions of people's mystical experiences or bad trips, sometimes they can actually on the surface look remarkably similar. What is different is the affective balance of it. And that's true for psychedelic experiences and also for psychotic experiences." [40:37]   Links: Dr. Lebedev on LinkedIn  Dr. Lebedev on Instagram  Dr. Lebedev on Threads Once Wellbeing Center website Once Wellbeing Center on Instagram Once Wellbeing Center on LinkedIn Psychedelic Medicine Association Porangui

Are surgical risks in EDS exaggerated, underestimated, or simply misunderstood? And how can patients tell the difference between a promising treatment and an expensive procedure being marketed ahead of the evidence? In this listener Q&A episode, host Dr. Linda Bluestein, the Hypermobility MD, is joined by recurring co-host Dr. Dacre Knight, Medical Director of the UVA Health EDS and Hypermobility Disorders Center, to tackle some of the most difficult questions submitted by the Bendy Bodies community. They begin with a candid discussion about surgery in EDS: why most patients do well, which complications are genuinely more likely, and why a surgeon's technical experience and procedural volume may matter just as much as their understanding of EDS (Ehlers-Danlos Syndromes) and HSD (Hypermobility Spectrum Disorders). They also explain how poorly controlled mast cell activation can derail recovery and why preparation before surgery may be more important than simply being reassured that everything will be fine. The conversation then turns to the striking mental health burden within the EDS and hypermobility population, including self-harm and cutting behaviors. Dr. Bluestein and Dr. Knight discuss why anxiety, depression, insomnia, and pain may sometimes reflect shared underlying biological drivers, and how treatments such as low dose naltrexone (LDN) may improve multiple symptoms at once when used thoughtfully. Listener questions lead them into the increasingly controversial world of cervical instability treatment, including PRP, the PICL procedure, and cervical fusion. What evidence actually exists? Who may benefit? What are the risks? And could treating mast cell activation and other contributors first reduce symptoms enough to avoid an invasive procedure altogether? They also take a critical look at IV infusion therapy, explaining when infusions may be medically appropriate, when they may cause more harm than benefit, and why clinics offering the same expensive infusion to nearly every patient before reviewing labs should immediately raise concern. The episode closes with an honest assessment of what is currently known about the cause of hypermobile EDS (hEDS), whether epigenetics may play a role, and why patients should pause whenever a clinician recommends a highly prescriptive treatment before completing a proper diagnostic evaluation. Takeaways: EDS surgery risks are real, but fear-based messaging can be harmful too. Most patients do well, especially when they choose an experienced, high-volume surgeon and address factors such as mast cell activation syndrome (MCAS) before the procedure. A kind surgeon is not necessarily a skilled surgeon. Bedside manner matters, but technical expertise, procedural volume, complication rates, and careful postoperative planning may matter even more. Mental health symptoms in EDS should not automatically be dismissed as “just anxiety.” Pain, poor sleep, mast cell activation, autonomic dysfunction, inflammation, and other biological drivers can profoundly affect emotional health and may need to be treated alongside psychological support. One treatment can sometimes improve far more than one symptom. When appropriately prescribed, low dose naltrexone (LDN) may improve pain, sleep, mood, anxiety, GI symptoms, and overall function by addressing shared underlying mechanisms. PRP and the PICL procedure are promising options for carefully selected patients, particularly given the significant risks and irreversible nature of cervical fusion. While early experience is encouraging, we still need higher-quality studies to better define who benefits most, what the long-term outcomes are, and how these procedures compare with other treatment options. Go http://www.AquaTru.com now for 20% off (your purifier) using promo code BENDY. Want to learn more about the UVA EDS Center? For Appointments and Questions: RUVAEDSCenter@uvahealth.org UVA EDS: https://www.uvahealth.com/healthy-practice/advancing-care-through-ehlers-danlos-clinic UVA EDS FAQ: https://www.uvahealth.com/support/eds/faq UVA Pediatric Integrative Medicine: https://childrens.uvahealth.com/specialties/integrative-health Want more Dr. Linda Bluestein, MD? Website: https://www.hypermobilitymd.com/ YouTube: https://www.youtube.com/@bendybodiespodcast Instagram: ⁠⁠⁠⁠https://www.instagram.com/hypermobilitymd/⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠https://www.facebook.com/BendyBodiesPodcast⁠⁠⁠⁠ X: ⁠⁠⁠⁠https://twitter.com/BluesteinLinda⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/in/hypermobilitymd/⁠⁠⁠⁠ Newsletter: ⁠⁠⁠⁠https://hypermobilitymd.substack.com/ Shop my Amazon store ⁠⁠⁠ https://www.amazon.com/shop/hypermobilitymd Dr. Bluestein's Recommended Herbs, Supplements and Care Necessities: https://us.fullscript.com/welcome/hypermobilitymd/store-start Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www.bendybodiespodcast.com/⁠⁠. YOUR bendy body is our highest priority!⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www.human-content.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠sales@human-content.com⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, David Debono, MD, Oncology Medical Director at Carelon Health, shares how technology, clinical pathways, and data-driven insights are helping improve cancer care while supporting physicians, expanding access, and delivering more personalized treatment for patients.

Pediatric Telehealth That Actually Works: 24/7 Access, All 50 States, Real Outcomes Host: Janae Sharp Guests: Lyndsey Garbi, MD, co-founder and CMO of Blueberry Pediatrics Pediatric access is broken, and parents, payers, and health systems are all feeling it. Lyndsey Garbi, MD, co-founder and CMO of Blueberry Pediatrics, joins Megan Antonelli to talk about what 24/7 pediatric telehealth actually looks like at national scale, what the at-home diagnostic kit changes for families, and why the licensing patchwork is quietly costing kids access to care. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Protein is everywhere these days – from protein pasta to protein cereal – but do these foods actually deliver the benefits they promise? And how much protein do we really need? We spoke with Marily Oppezzo, PhD, MS, RDN, an instructor of medicine at the Stanford Prevention Research Center and head of the nutrition pillar at Stanford Lifestyle Medicine, about how much protein the average adult needs for overall health and muscle maintenance, whether high-protein diets offer meaningful benefits, and how protein needs change with age and activity level. She also explains the differences between animal and plant proteins and what the latest research says about protein and long-term health. Credits Host: Neha Pathak, MD, FACP, DipABLM Producer/Editor: Lauren Summers Show Notes: Lauren Summers Guest: Marily Oppezzo, PhD, MS, RDN See omnystudio.com/listener for privacy information.

In this special crossover episode, recorded live at the American Diabetes Association's Scientific Sessions in New Orleans, the hosts of the ADA's professional podcasts—DOC Updates, Diabetes Care "On Air", DiabetesBio, and The Points of CARE—come together to discuss key highlights and groundbreaking research presented at the 2026 meeting. They share expert insights across the bench-to-bedside spectrum, including basic science, clinical research, and the latest in diabetes care and education. Tune in for thoughtful reflections on what this year's findings mean for clinical practice and future research. Available now across all ADA professional podcast channels. Featured Podcasts: DOC Updates – ADA's podcast for primary care Diabetes Care "On Air" – From ADA's clinical research journal, Diabetes Care DiabetesBio – From ADA's flagship research journal, Diabetes The Points of CARE - The official podcast of Diabetes, Obesity, and CardioMetabolic CARE Join the Discussion with: Alice Cheng, MD – Co-host of Diabetes Care "On Air" Kirk Habegger, PhD – Co-host of DiabetesBio Michael Rickels, MD, MS – Co-host of Diabetes Care "On Air" Neil Skolnik, MD – Co-host of DOC Updates and Diabetes Day by Day Kevin Williams, PhD – Co-host of DiabetesBio Richard Beaser, MD – Co-host of The Points of CARE

In today's episode, we spoke with John N. Allan, MD. Dr Allan is an associate attending physician at New York-Presbyterian Hospital and an associate professor of clinical medicine at Weill Cornell Medical College in New York, New York. In our exclusive interview, Dr Allan discussed his review of the currently approved fixed-duration regimens for chronic lymphocytic leukemia (CLL). Regimens like venetoclax (Venclexta) plus obinutuzumab (Gazyva), ibrutinib (Imbruvica) plus venetoclax, acalabrutinib (Calquence) plus venetoclax, and venetoclax plus rituximab (Rituxan) were all regimens that Allan comparatively delved into. Additionally, Allan discussed insight provided by the review that clinical trials lack, remaining gaps of unmet needs for fixed-duration regimens in CLL, and what research is necessary for the field to conduct moving forward. 

In today's episode, we spoke with Tanios S. Bekaii-Saab, MD. Dr Bekaii-Saab is the David F. and Margaret T. Grohne Professor of Novel Therapeutics for Cancer Research I, at the Mayo Clinic College of Medicine and Science, the division chair of Hematology/Medical Oncology at Mayo Clinic, and co-leader of the Advanced Clinical and Translational Science Program and the disease group leader for Gastrointestinal Cancers for the Mayo Clinic Comprehensive Cancer Center in Phoenix, Arizona.In our exclusive interview, Dr Bekaii-Saab discussed findings from the final analysis of cohort 3 of the phase 3 BREAKWATER trial (NCT04607421), which were presented at the 2026 ASCO Annual Meeting. These data showed that encorafenib (Braftovi) plus cetuximab (Erbitux) and FOLFIRI (leucovorin, 5-fluorouracil, and irinotecan) significantly improved outcomes compared with standard of care in patients with BRAF V600E–mutant metastatic colorectal cancer (mCRC), building on previously reported data from the trial that led to the February 2026 full FDA approval of encorafenib plus cetuximab and modified FOLFOX6 (leucovorin calcium, fluorouracil, and oxaliplatin) for this patient population. He also highlighted promising bispecific agents targeting VEGF and PD-1, as well as the promise of KRAS G12C inhibitors like calderasib (MK-1084) and sotorasib (Lumakras). Finally, he emphasized that minimal residual disease testing is prognostic and potentially predictive, and can aid in personalized mCRC management.

In this episode, David N. Bernstein, MD, PhD, MBA, MEI, Harvard Orthopaedic Surgeon, shares his perspective on the future of orthopedic care, discussing value-based healthcare, ambulatory surgery centers, AI, and why measuring the outcomes that matter most to patients will shape the next generation of care delivery.

In this episode, David N. Bernstein, MD, PhD, MBA, MEI, Harvard Orthopaedic Surgeon, shares his perspective on the future of orthopedic care, discussing value-based healthcare, ambulatory surgery centers, AI, and why measuring the outcomes that matter most to patients will shape the next generation of care delivery.

In this episode, Sam Ashoo, MD and Dr. T.R. Eckler, MD discuss the July 2026 Emergency Medicine Practice article, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management in the Emergency Department.0:17 – Intro & sponsor promo1:09 – Episode introduction4:03 – Definitions: SJS vs. TEN vs. "overlap" by body surface area6:12 – Pathophysiology9:52 – Incidence and rarity of the disease10:53 – Differential diagnosis & clinical presentation clues12:08 – Prehospital care & fluid resuscitation considerations13:47 – ED history-taking: medications, infections, rash progression14:47 – Physical exam findings16:46 – Diagnostic studies18:12 – Scoring systems: SCORTEN and ABCD-1020:50 – Treatment goals23:57 – Wound care principles24:43 – Mechanical ventilation risk factors26:02 – Other possible therapies27:50 – Specialty consults & special populations29:06 – Ophthalmologic treatment31:17 – HIV patients and elevated risk31:55 – Emerging therapies & AI-based diagnostic tools32:57 – Five key clinical takeaways34:37 – Closing remarks & sponsor sign-offSubscribers, take the CME test here.Emergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

What if telepathy is real and neuroscience has been looking at it the wrong way all along?In this episode of Mayim Bialik's Breakdown, Dr. Diane Hennacy, MD (neuropsychiatrist, neuroscientist, consciousness researcher known for her groundbreaking work with autistic savants and other neurodivergent individuals) shares the astonishing evidence that led her to investigate telepathy, precognition, consciousness, and the hidden capabilities of the human mind.Dr. Hennacy reveals the unbelievable things she witnessed while testing nonspeaking autistic individuals, why statistically significant psi phenomena continue to challenge mainstream scientific assumptions, and what it would actually take to prove telepathy scientifically. She explains why scientists struggle to recreate psi abilities in laboratory settings, how skeptics critique her work, and why researchers in the field believe the word "telepathy" itself may be preventing serious scientific engagement.We explore groundbreaking questions about consciousness, including whether telepathic abilities could help explain how babies acquire language so effortlessly, why Dr. Hennacy believes all humans may possess latent telepathic abilities, and how modern society may have caused many of us to lose access to them. She also explains why telepathy cannot be explained by quantum computation in the brain, even while discussing how savant abilities may reveal previously unknown computational capacities of the human mind.Dr. Hennacy teases her emerging model of how the brain actually works, shares extraordinary case studies involving verified precognitive dreams, and discusses where consciousness goes during dream states. She explains why dreams may provide a window into the unconscious, how they reveal our interconnectedness with others, which dreams deserve special attention, and why reports of precognition continue to fascinate both researchers and experiencers alike.We also dive into why psychedelic experiences so often include reports of telepathy, the shared physiological traits found among individuals who report psychic abilities, and the mystical experiences with a psychic that first sparked Dr. Hennacy's interest in studying these controversial phenomena scientifically.The conversation expands into autism research, exploring how autistic individuals process information differently, why so many nonspeaking autistic people experience synesthesia, reports of seeing auras, and what the autism community can teach the rest of humanity about cognition, perception, communication, and consciousness itself.Dr. Hennacy discusses the profound impact of The Telepathy Tapes podcast, why it resonated so deeply with autistic individuals and their families, and how it helped many people feel seen, heard, and understood for the first time.We also explore acquired savant syndrome and its most mind-blowing documented cases, potential causes behind the apparent rise in autism, and how environmental pressures may be contributing to increasing diversity in human cognitive styles. Are humans evolving toward greater cognitive specialization, or losing something we once possessed?Other topics include:- NDE-adjacent experiences from Dr. Hennacy's youth and how later discoveries in physics shaped her interpretation of those events- Brain function, consciousness, & the limits of current neuroscience- Anxiety, OCD, & emotional dysregulation in nonspeaking autistic individuals- Scientific challenges of measuring telepathy quantitatively- Why more research into the gut microbiome could revolutionize psychiatry- Implications of telepathy research for human cognitive development- Why we should operate from a higher level of consciousness when interacting with AI- How evolving environments shape cognitive diversity across humanityIf consciousness is far stranger than we imagine, this conversation may completely change how you think about autism, dreams, telepathy, AI, neuroscience, and what it means to be human!Learn more about The Hennacy Institute: https://hennacyinstitute.org/Follow us on Substack for Exclusive Bonus Content: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bialikbreakdown.substack.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BialikBreakdown.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube.com/mayimbialik⁠⁠⁠See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The mates discuss Dario vs. Jensen's open vs. closed AI debate, OpenAI and Anthropic teaming up to lobby in DC, and Kimi K3's global expansion. Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends   Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 Salim Ismail is the founder of Open ExO, a GP at Exponential Venture Capital/The Organizational Singularity Fund and a sought after global speaker and thought leader. Dave Blundin is the founder & GP of Link Ventures Dr. Alexander Wissner-Gross is a computer scientist and founder of Reified – My companies: Apply to Dave's and my new fund:https://qr.diamandis.com/linkventureslanding     Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy   Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter  _ Connect with Peter: X Instagram Substack Website Xprize A360 Connect with Dave: Web X LinkedIn Instagram TikTok Connect with Salim: LinkedIn X Join Salim's 10X Shift Subscribe to Salim's YouTube channel Exponential Venture Capital Connect with Alex Website LinkedIn X Email Substack  Spotify Threads Listen to MOONSHOTS: Apple YouTube – *Recorded on July 28, 2026 *The views expressed by me and all guests are personal opinions and do not constitute Financial, Medical, or Legal advice. Learn more about your ad choices. Visit megaphone.fm/adchoices

Suboptimal sleep quality and quantity are associated with higher body mass index and more difficulty losing weight. In this podcast, JAMA Insights author Atul Malhotra, MD, from the University of California, San Diego, discusses evidence regarding sleep and obesity with JAMA Deputy Editor Mary McDermott, MD. Related Content: Sleep Health and Obesity

What if telepathy is real and neuroscience has been looking at it the wrong way all along?In this episode of Mayim Bialik's Breakdown, Dr. Diane Hennacy, MD (neuropsychiatrist, neuroscientist, consciousness researcher known for her groundbreaking work with autistic savants and other neurodivergent individuals) shares the astonishing evidence that led her to investigate telepathy, precognition, consciousness, and the hidden capabilities of the human mind.Dr. Hennacy reveals the unbelievable things she witnessed while testing nonspeaking autistic individuals, why statistically significant psi phenomena continue to challenge mainstream scientific assumptions, and what it would actually take to prove telepathy scientifically. She explains why scientists struggle to recreate psi abilities in laboratory settings, how skeptics critique her work, and why researchers in the field believe the word "telepathy" itself may be preventing serious scientific engagement.We explore groundbreaking questions about consciousness, including whether telepathic abilities could help explain how babies acquire language so effortlessly, why Dr. Hennacy believes all humans may possess latent telepathic abilities, and how modern society may have caused many of us to lose access to them. She also explains why telepathy cannot be explained by quantum computation in the brain, even while discussing how savant abilities may reveal previously unknown computational capacities of the human mind.Dr. Hennacy teases her emerging model of how the brain actually works, shares extraordinary case studies involving verified precognitive dreams, and discusses where consciousness goes during dream states. She explains why dreams may provide a window into the unconscious, how they reveal our interconnectedness with others, which dreams deserve special attention, and why reports of precognition continue to fascinate both researchers and experiencers alike.We also dive into why psychedelic experiences so often include reports of telepathy, the shared physiological traits found among individuals who report psychic abilities, and the mystical experiences with a psychic that first sparked Dr. Hennacy's interest in studying these controversial phenomena scientifically.The conversation expands into autism research, exploring how autistic individuals process information differently, why so many nonspeaking autistic people experience synesthesia, reports of seeing auras, and what the autism community can teach the rest of humanity about cognition, perception, communication, and consciousness itself.Dr. Hennacy discusses the profound impact of The Telepathy Tapes podcast, why it resonated so deeply with autistic individuals and their families, and how it helped many people feel seen, heard, and understood for the first time.We also explore acquired savant syndrome and its most mind-blowing documented cases, potential causes behind the apparent rise in autism, and how environmental pressures may be contributing to increasing diversity in human cognitive styles. Are humans evolving toward greater cognitive specialization, or losing something we once possessed?Other topics include:- NDE-adjacent experiences from Dr. Hennacy's youth and how later discoveries in physics shaped her interpretation of those events- Brain function, consciousness, & the limits of current neuroscience- Anxiety, OCD, & emotional dysregulation in nonspeaking autistic individuals- Scientific challenges of measuring telepathy quantitatively- Why more research into the gut microbiome could revolutionize psychiatry- Implications of telepathy research for human cognitive development- Why we should operate from a higher level of consciousness when interacting with AI- How evolving environments shape cognitive diversity across humanityIf consciousness is far stranger than we imagine, this conversation may completely change how you think about autism, dreams, telepathy, AI, neuroscience, and what it means to be human!Watch the Stuart Fails to Save the Universe Official Podcast on HBO Max, the HBO Max YouTube channel, or listen wherever you get your podcasts. https://link.mgln.ai/StuartHead to https://forkfulmeals.com/BREAKDOWN for 50% off your first order today!Machine Washable Rugs, Made Better. For a limited time only, our listeners get 10% off + free shipping at https://www.tumbleliving.com/BREAK #Tumble #adHead to https://www.Superpower.com and use code BREAK at checkout for $20 off your membership. Unlock your new health intelligence. 100+ biomarkers. Every year. Detects early signs of 1,000+ conditions. #superpowerpodMake your summer wardrobe feel easier. Go to https://www.quince.com/breakdown for free shipping on your order and 365-day returns.Go to https://helixsleep.com/breakdown to receive 20% off sitewide, 25% of Luxe Mattresses and 30% off Elite Mattresses.Upgrade your kitchen with Our Place today. Visit fromourplace.com/BREAK and use code BREAK for 10% off sitewide.Learn more about The Hennacy Institute: https://hennacyinstitute.org/Follow us on Substack for Exclusive Bonus Content: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bialikbreakdown.substack.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BialikBreakdown.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube.com/mayimbialik⁠⁠⁠See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Jomboy & Jake each present gameplans for how to attack the 2026 trade deadline and address every need for the Yankees This episode is brought to you by Samuel Adams.  https://www.samueladams.com/cheers-to-250   Use our code for 10% off your next set of MLB tickets on SeatGeek*: https://seatgeek.onelink.me/RrnK/YANKS2026. Sponsored by SeatGeek. *Restrictions apply. Max $20 discount Download the Fanatics Sportsbook app , use code JOMBOY https://fanatics.onelink.me/5kut/JOMBOY New customers who sign up and Bet $5, Get $100 in FanCash*. Use FanCash on bonus bets, profit boosts, team gear and more on Fanatics.com.   *New customers in AZ, CO, CT, DC, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NY, OH, PA, TN, VA, VT, WV, or WY. Must toggle on this promotion in your bet slip and wager $5+ cash on any market (min. odds -500) within 7 days of account opening to receive $100 in FanCash. Promotional FanCash expires 7 days from issuance (at 11:59pm ET). Terms, including FanCash terms apply-see Fanatics Sportsbook app. Use FanCash on bonus bets, profit boosts, team gear on Fanatics.com and so much more. +++++ Timestamps: 0:00 We Made Trade Deadline Plans 3:20 How Did We Go About This? 5:05 Jomboy's Plan 29:35 Jake's Plan 48:15 What Else Can They Do? Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.